Determinants of postembolization syndrome after hepatic chemoembolization
D A Leung1, J E Goin, C Sickles
1Division of Interventional Radiology, Hospital of the University of Pennsylvania, Philadelphia, USA.
Journal of Vascular and Interventional Radiology : JVIR
|April 5, 2001
Summary
Identifying risk factors for postembolization syndrome (PES) after hepatic chemoembolization is crucial. Avoiding gallbladder embolization and considering re-embolization can help manage PES and hospitalization risks.
Area of Science:
- Interventional Radiology
- Hepatobiliary Oncology
Background:
- Postembolization syndrome (PES) is a common complication of hepatic chemoembolization, leading to hospitalization.
- Predicting PES risk can optimize patient counseling and treatment planning.
Purpose of the Study:
- To identify procedural variables associated with PES and hospitalization duration after hepatic chemoembolization.
- To inform risk stratification and management strategies for patients undergoing this procedure.
Main Methods:
- Retrospective analysis of 70 hepatic chemoembolization procedures in 29 patients.
- Evaluation of variables including gallbladder embolization, lobe embolized, volume embolized, tumor burden, prior embolization, and chemoembolic dose.
- Logistic regression to assess the association between procedural variables and PES/hospitalization.
Main Results:
- Gallbladder embolization and higher chemoembolic dose significantly increased PES risk and hospitalization length.
- Previous embolization was associated with a reduced risk of PES and shorter hospitalization.
- Trends toward statistical significance were observed for gallbladder embolization, dose, and prior embolization.
Conclusions:
- Procedural factors like gallbladder embolization and chemoembolic dose predict PES severity and hospitalization.
- Avoiding gallbladder embolization may decrease PES incidence.
- Re-embolization of previously treated vessels shows potential for reduced toxicity and outpatient management selection.
